AmorChem

AmorChem is a Montreal-based venture capital firm specializing in early-stage investments in life sciences companies, particularly those emerging from academic research. Since its inception in 2011, the firm has financed over 30 university projects and established several biotechnology companies, each with its own groundbreaking therapeutic paradigm. AmorChem's innovative business model involves financing research-stage projects to enable them to reach pre-clinical proof-of-concept within 18-24 months, after which they either sell the projects to large biotechnology or pharmaceutical companies or bundle them into new spin-off companies. The firm's principal limited partners include Investissement-Québec, FIER Partenaires, Fonds de solidarité FTQ, and Merck & Co. AmorChem's portfolio includes companies such as Mperia Therapeutics Inc., SemaThera Inc., Corbin Therapeutics Inc., SpecificiT Pharma Inc., and Eosinate Therapeutics Inc. The firm is headquartered at 1 Westmount Square, Suite 800, Montreal, Quebec, Canada. For more information, visit their website at https://amorchem.com/ or contact them via email at info@amorchem.com or by phone at (514) 849-7696.

AmorChem's investment strategy focuses on identifying promising life science projects originating from Quebec-based universities and research centres. The firm actively manages these projects, providing seed and early-stage funding, contributing management leadership, and offering technical and regulatory expertise. This approach has led to successful transactions with pharmaceutical companies and the creation of spin-off companies. AmorChem's portfolio companies include Mperia Therapeutics Inc., SemaThera Inc., Corbin Therapeutics Inc., SpecificiT Pharma Inc., and Eosinate Therapeutics Inc. The firm's principal limited partners are Investissement-Québec, FIER Partenaires, Fonds de solidarité FTQ, and Merck & Co.

For more information, visit their website at https://amorchem.com/ or contact them via email at info@amorchem.com or by phone at (514) 849-7696.